-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Sagimet Biosciences Inc. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- Sagimet Biosciences Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2025 was $3,413,000, a 14% increase year-over-year.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2025 was $4,556,000.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $61,683,000, a 590% decline from 2023.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $12,580,000.